| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Oramed Pharmaceuticals Inc. (ORMP) have been net sellers, shedding 50,000 shares worth roughly $226K on balance.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 4.14M | $17.10M | - | |
| Other | 1.55M | $6.40M | - | |
| COO | 1.33M | $5.49M | - | |
| CFO | 861.1K | $3.56M | - | |
| Dir | 168.0K | $693.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 21, 2022 | Kevin Rakin77 | Director | Sell | 10,000 | $9.41 | $94,096.00 | -17.6% | -55.0% | -76.4% | |
| Nov 1, 2021 | Arie Mayer76 | Director | Sell | 3,000 | $25.60 | $76,800.00 | -100% | -64.3% | -73.0% | |
| Sep 16, 2021 | Kevin Rakin77 | Director | Sell | 21,100 | $20.99 | $442,829.92 | -27.0% | -27.7% | -63.2% | |
| Aug 9, 2021 | Nadav Kidron67 | President and CEO | Sell | 220,000 | $20.11 | $4,423,144.00 | -25.3% | +41.1% | -59.4% | |
| Sep 9, 2019 | Leonard Sank | Director | Buy | 25,000 | $2.92 | $73,000.00 | +7.1% | - | - | |
| Jul 18, 2019 | Leonard Sank | Director | Buy | 54,517 | $3.59 | $195,710.78 | +18.5% | - | - | |
| Jul 11, 2019 | Leonard Sank | Director | Buy | 1,320 | $3.22 | $4,250.40 | +0.4% | - | - | |
| Aug 9, 2018 | Aviad Friedman | Director | Buy | 2,500 | $4.95 | $12,370.00 | +25.8% | - | - | |
| Jul 11, 2018 | Nadav Kidron67 | President and CEO | Buy | 122 | $5.92 | $722.18 | - | - | - | |
| Jul 10, 2018 | Nadav Kidron67 | President and CEO | Sell | 61 | $5.98 | $364.97 | - | - | - |